These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18843833)

  • 1. Metformin: effective in the prevention of new-onset type 2 diabetes?
    Drown DJ
    Prog Cardiovasc Nurs; 2008; 23(2):93-4. PubMed ID: 18843833
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention.
    Goodarzi MO; Azziz R
    Am J Med; 2008 Aug; 121(8):e9; author reply e11. PubMed ID: 18691471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of type 2 diabetes mellitus].
    Palitzsch D; Bührlen M
    MMW Fortschr Med; 2012 May; 154(9):45-8. PubMed ID: 22715631
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
    Teede HJ; Meyer C; Norman RJ
    Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.
    Lautatzis ME; Goulis DG; Vrontakis M
    Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin for the treatment of the polycystic ovary syndrome.
    Barbieri RL; Gargiulo AR
    Minerva Ginecol; 2004 Feb; 56(1):63-79. PubMed ID: 14973411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome.
    Oppelt PG; Mueller A; Jentsch K; Kronawitter D; Reissmann C; Dittrich R; Beckmann MW; Cupisti S
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):633-7. PubMed ID: 19998243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and gestational diabetes.
    Glueck CJ; Goldenberg N; Streicher P; Wang P
    Curr Diab Rep; 2003 Aug; 3(4):303-12. PubMed ID: 12866993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should patients with polycystic ovarian syndrome be treated with metformin?: an enthusiastic endorsement.
    Nestler JE
    Hum Reprod; 2002 Aug; 17(8):1950-3. PubMed ID: 12151419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention and treatment of the complications of polycystic ovarian syndrome--the significance of evidence-based, interdisciplinary management].
    Gődény S; Csenteri OK
    Orv Hetil; 2015 Dec; 156(50):2018-26. PubMed ID: 26639643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristic of metformin for treatment of impaired glucose tolerance].
    Ishida W; Satoh J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
    Sharma ST; Nestler JE
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin in polycystic ovary syndrome.
    Fisken RA
    N Engl J Med; 2008 Apr; 358(17):1866-7; author reply 1868. PubMed ID: 18437727
    [No Abstract]   [Full Text] [Related]  

  • 15. Topics in type 2 diabetes.
    Bloomgarden ZT
    Diabetes Care; 1997 Sep; 20(9):1487-90. PubMed ID: 9283803
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
    Palomba S; Falbo A; Zullo F; Orio F
    Endocr Rev; 2009 Feb; 30(1):1-50. PubMed ID: 19056992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.
    Goldberg RB; Mather K
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2077-90. PubMed ID: 22895669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin for the treatment of the polycystic ovary syndrome.
    Nestler JE
    N Engl J Med; 2008 Jan; 358(1):47-54. PubMed ID: 18172174
    [No Abstract]   [Full Text] [Related]  

  • 20. Polycystic ovary syndrome in adolescents.
    Kent SC; Legro RS
    Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.